Evaluation of Adefovir PBPK Model to Assess Biomarker-Informed OAT1 Drug-Drug Interaction and Effect of Chronic Kidney Disease. [PDF]
Tan SPF +4 more
europepmc +1 more source
stormTB: a web-based simulator of a murine minimal-PBPK model for anti-tuberculosis treatments. [PDF]
Visintainer R +7 more
europepmc +1 more source
A Parent-Metabolite Middle-Out PBPK Model for Genistein and Its Glucuronide Metabolite in Rats: Integrating Liver and Enteric Metabolism with Hepatobiliary and Enteroluminal Transport to Assess Glucuronide Recycling. [PDF]
Ramisetty BS, Singh R, Hu M, Wang MZ.
europepmc +1 more source
Development of a Physiologically Based Pharmacokinetic (PBPK) Model for F-53B in Pregnant Mice and Its Extrapolation to Humans. [PDF]
Zhang J +7 more
europepmc +1 more source
Model-Informed Radiopharmaceutical Therapy Optimization: A Study on the Impact of PBPK Model Parameters on Physical, Biological, and Statistical Measures in 177Lu-PSMA Therapy. [PDF]
Abdollahi H, Fele-Paranj A, Rahmim A.
europepmc +1 more source
Can 3D Printed Tablets Be Bioequivalent and How to Test It: A PBPK Model Based Virtual Bioequivalence Study for Ropinirole Modified Release Tablets. [PDF]
Shuklinova O +7 more
europepmc +1 more source
PBPK model reporting template for chemical risk assessment applications
Physiologically-based pharmacokinetic (PBPK) modeling analysis does not stand on its own for regulatory purposes but is a robust tool to support drug/chemical safety assessment.
Michelle Embry +2 more
exaly +2 more sources
The Implications of Using a Physiologically Based Pharmacokinetic (PBPK) Model for Pesticide Risk Assessment [PDF]
Background: A physiologically based pharmacokinetic (PBPK) model would make it possible to simulate the dynamics of chemical absorption, distribution, metabolism, and elimination (ADME) from different routes of exposures and, in theory, could be used to ...
Chensheng Lu
exaly +2 more sources

